In the context of Alzheimer’s disease, legumain phosphorylation at S226 by SRPK2 led to accumulation of cytoplasmic legumain, promoting cleavage of tau, APP, and SRPK2 itself (110). The gene discussed is LGMN; the disease is Alzheimer disease.